Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Using well-worded warning texts could reduce DNAs, potentially save NHS £64 million

Using well-worded warning texts could reduce DNAs, potentially save NHS £64 million

Saint Louis University receives NIH grant to investigate development of new drugs to treat bone diseases

Saint Louis University receives NIH grant to investigate development of new drugs to treat bone diseases

New software programs may help speed up drug discovery process for diabetes and other diseases

New software programs may help speed up drug discovery process for diabetes and other diseases

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

Promising drug candidate for chronic intractable itch

Promising drug candidate for chronic intractable itch

Edward-Elmhurst Health, UChicago Medicine agree to provide advanced care to children in west and southwest regions

Edward-Elmhurst Health, UChicago Medicine agree to provide advanced care to children in west and southwest regions

ACR releases new recommendations for treatment of AS and non-radiographic axial SpA

ACR releases new recommendations for treatment of AS and non-radiographic axial SpA

AbbVie plans to advance ABT-494 to Phase 3 studies in rheumatoid arthritis

AbbVie plans to advance ABT-494 to Phase 3 studies in rheumatoid arthritis

AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis

AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis

Salsalate drug offers new hope for treating Alzheimer's disease and FTD

Salsalate drug offers new hope for treating Alzheimer's disease and FTD

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Yoga improves physical, mental wellbeing of people living with common forms of arthritis

Yoga improves physical, mental wellbeing of people living with common forms of arthritis

Experts and researchers develop new classification criteria for gout

Experts and researchers develop new classification criteria for gout

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

WFU awarded $6 million federal grant to further study knee osteoarthritis

WFU awarded $6 million federal grant to further study knee osteoarthritis

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

AccentHealth launches new digital patient engagement platform

AccentHealth launches new digital patient engagement platform

PAH treatments less effective in CTD-associated disease

PAH treatments less effective in CTD-associated disease

Arthritis increases risk of falling into poverty, new research shows

Arthritis increases risk of falling into poverty, new research shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.